A Case of Encephalopathy in an Immunocompetent Adult with Persistent Parvovirus B19 Viremia

Ariel Antezana1, *, Ilya Kister2, Joseph Herbert2
1 Neuromedical Clinic of Central Louisiana, Alexandria, LA, USA
2 NYU School of Medicine, New York, NY, USA

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 2671
Abstract HTML Views: 1621
PDF Downloads: 861
Total Views/Downloads: 5153
Unique Statistics:

Full-Text HTML Views: 1342
Abstract HTML Views: 961
PDF Downloads: 573
Total Views/Downloads: 2876

Creative Commons License
© Antezana et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Neuromedical Clinic of Central Louisiana, Alexandria, LA, USA;, E-mail:


Parvovirus B19 (PVB19) is a ubiquitous airborne virus; it is well known to cause erythema infectiosum (fifth disease) in children. Neurologic complications after PVB19 exposure are thought to be transitory and infrequent in the adult population. Herein, we report an interesting case of a young woman who developed cognitive deficits, white matter changes and persisting viremia for over a year after exposure to PVB19.

Keywords: Cognitive deficits, encephalopathy, parvovirus B19, white matter changes.